Pregled bibliografske jedinice broj: 606459
Single Nucleotide Polymorphism in the Interleukin 12B Gene is Associated With Risk for Breast Cancer Development
Single Nucleotide Polymorphism in the Interleukin 12B Gene is Associated With Risk for Breast Cancer Development // Scandinavian journal of immunology, 76 (2012), 3; 329-335 doi:10.1111/j.1365-3083.2012.02736.x (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 606459 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Single Nucleotide Polymorphism in the Interleukin 12B Gene is Associated With Risk for Breast Cancer Development
Autori
Kaarvatn, Marikken H. ; Vrbanec, Jurica ; Kulić, Ana ; Knežević, Jelena ; Petričević, Branka ; Balen, Sanja ; Vrbanec, Damir ; Dembić, Zlatko
Izvornik
Scandinavian journal of immunology (0300-9475) 76
(2012), 3;
329-335
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
IL12B; breast cancer; SNP; genotype
Sažetak
We analysed the association of a single nucleotide polymorphism (SNP) in the gene encoding the IL-12 subunit p40 (IL12B, rs3212227, A>C) with breast cancer. The SNPs allelic and genotypic frequencies were compared between patients (n = 191) and healthy (n = 194) women in a case-control study from Croatia. The major allele (A) was associated with susceptibility to breast cancer (P = 0.003 ; OR = 1.67 ; 95% CI: 1.17-2.38). Likewise, the minor allele (C) was significantly correlated with protection (P = 0.003 ; OR = 0.60 ; 95% CI: 0.42-0.86). At the genotype level, AA homozygosity was significantly associated with predisposition to disease (P = 0.013 ; OR = 1.68, 95% CI: 1.09-2.59), whereas the minor allele homozygosity (CC) was correlated with protection to disease (P = 0.020, OR = 0.28, 95% CI: 0.09-0.91). The heterozygous genotype showed no significant correlation with disease. The product of the IL12B gene (IL-12 p40) can either form a homodimeric cytokine or be part of two pro-inflammatory (IL-12 and IL-23) cytokines. It is presently unclear whether the major allele is associated with higher or lower protein levels of IL-12 p40 and IL-12 p70, which are critical in inflammation and adaptive immune responses. However, as the A allele is high producer of IL12B (p40) mRNA, these results might imply that higher levels of IL-12 p40 (either as homodimers or joined with one or both of the other two subunits) predispose to breast cancer.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Projekti:
098-0982464-2394 - Gensko liječenje tumora djelovanjem na molekule imunološkog sustava (Pavelić, Jasminka, MZOS ) ( CroRIS)
108-1080058-0046 - KARCINOM DOJKE-MOLEKULARNE,GENETSKE I KLINIČKE KARAKTERISTIKE (Vrbanec, Damir, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka,
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb,
Klinički bolnički centar Rijeka
Profili:
Damir Vrbanec
(autor)
Branka Petričević
(autor)
Ana Kulić
(autor)
Jelena Knežević
(autor)
Sanja Balen
(autor)
Zlatko Dembić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE